At The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), our vision is to create a cancer-free world, one person, one discovery at a time. This underlies everything we do in working to eradicate cancer through research that translates to innovative and highly targeted patient care. The OSUCCC - James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the na-tion's largest public universities. Cancer is no longer defined solely by stage and location, but rather by its biologic and genetic makeup. There is no routine cancer - it is different in each person. Working together and utiliz-ing state-of-the-art facilities and technology, clinicians and researchers at Ohio State are speed-ing the development and delivery of treatments that target the molecules and markers fueling each person's unique cancer.
The NCI-Designated Cancer Centers program is a major anchor of the nation's cancer research effort. At any given time, hundreds of cutting-edge research studies are under way at NCI-Designated Cancer Centers, ranging from basic laboratory research to clinical assess-ments of new treatments. Many of these studies are collaborative and may involve sev-eral research centers and other partners in industry and the community.
NCI recently added a new institution to the program and awarded the comprehensive designation to four existing NCI-Designated Cancer Centers.
Each NCI-Designated Cancer Center receives a core support grant from NCI that funds the critical research infrastructure of the center, in addition to the funding received from individual competitive research grants and contracts with NCI.
The funding provided by the core grants is essential for the efficient conduct of re-search at the centers and for driving the nation's progress against cancer.